Introduction
The report presents a detailed analysis of the Tuberculosis diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Tuberculosis definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:
- Hospitals
- Commercial/Private Labs
- Physician Offices
- Public Health Labs
For each country, in addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Tuberculosis tests.
Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.Contains 208 pages and 15 tables
Table of Contents
for Tuberculosis: US, Europe, Japan--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers
Table of Content - click REQUEST A SAMPLE BUTTON
List Of Tables
in Tuberculosis: US, Europe, Japan--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers
Competitive Assessments
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- ID Biomedical/GSK
- Kreatech/Leica
- Lonza
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher/Life Technology
- Wallac/PE
- Wako
Additional Details
Publisher
Venture Planning Group (VPG)
Publisher Information
Reference
58837 | VPID18921
Number of Pages
208
Report Format

Related Reports
Title | Date Published | Price from | More Details |
---|---|---|---|
SAVE 15% today! Global Tuberculosis Partnering 2010 to 2016 The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce... | 01 Nov 2016 by Current Partnering | USD $1,271 (normally USD $1,495) |
More Info |
SAVE 15% today! Global Tuberculosis Partnering 2010 to 2016 The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and acce... | 01 Oct 2016 by Current Partnering | USD $1,271 (normally USD $1,495) |
More Info |
SAVE 15% today! Pulmonary Tuberculosis Global Clinical Trials Review, H2, 2016 Pulmonary Tuberculosis Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial rep... | 31 Aug 2016 by Global Data | USD $2,125 (normally USD $2,500) |
More Info |
SAVE 15% today! Pulmonary Tuberculosis Global Clinical Trials Review, H2, 2016 Pulmonary Tuberculosis Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial rep... | 31 Aug 2016 by Global Data | USD $2,125 (normally USD $2,500) |
More Info |
SAVE 15% today! Respiratory Diseases: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review About this ReportThis new 366-page report from VPG Market Research presents detailed analysis of the... | 28 Jun 2016 by Venture Planning Group (VPG) | USD $8,373 (normally USD $9,851) |
More Info |
SAVE 15% today! France Respiratory Disease Market: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review About This ReportThis new 282-page report from VPG Market Research presents detailed analysis of the... | 28 Jun 2016 by Venture Planning Group (VPG) | USD $1,658 (normally USD $1,951) |
More Info |
SAVE 15% today! Germany Respiratory Disease Market: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review About This ReportThis new 283-page report from VPG Market Research presents detailed analysis of the... | 28 Jun 2016 by Venture Planning Group (VPG) | USD $1,658 (normally USD $1,951) |
More Info |
SAVE 15% today! Tuberculosis: US, Europe, Japan--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers The report presents a detailed analysis of the Tuberculosis diagnostics market in the US, Europe (Fr... | 24 Jun 2016 by Venture Planning Group (VPG) | USD $3,698 (normally USD $4,351) |
More Info |
SAVE 15% today! Tuberculosis Global Clinical Trials Review, H1, 2016 Tuberculosis Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical trial report, “Tube... | 29 Feb 2016 by Global Data | USD $2,125 (normally USD $2,500) |
More Info |
SAVE 15% today! Mycobacterium Tuberculosis Infections Global Clinical Trials Review, H2, 2015 Mycobacterium Tuberculosis Infections Global Clinical Trials Review, H2, 2015SummaryGlobalData's cli... | 30 Oct 2015 by Global Data | USD $2,125 (normally USD $2,500) |
More Info |
This report is published by Venture Planning Group (VPG)
Download Free Report Summary PDF

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.
Ordering Information
Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.
Accepted Card Types

Buy now using our secure payment system.